Nishioka Kenya, Funayama Manabu, Vilariño-Güell Carles, Ogaki Kotaro, Li Yuanzhe, Sasaki Ryogen, Kokubo Yasumasa, Kuzuhara Shigeki, Kachergus Jennifer M, Cobb Stephanie A, Takahashi Hirohide, Mizuno Yoshikuni, Farrer Matthew J, Ross Owen A, Hattori Nobutaka
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Parkinsonism Relat Disord. 2014 Jun;20(6):659-61. doi: 10.1016/j.parkreldis.2014.03.004. Epub 2014 Mar 18.
Pathogenic mutations in the EIF4G1 gene were recently reported as a cause of autosomal dominant parkinsonism. To assess the frequency of EIF4G1 mutations in the Japanese population we sequenced the entire gene coding region (31 exons) in 95 patients with an apparent autosomal dominant inherited form of Parkinson's disease. We detected three novel point mutations located in a poly-glutamic acid repeat within exon 10. These variants were screened through 224 Parkinson's disease cases and 374 normal controls from the Japanese population. We detected the poly-glutamic acid deletion in exon 10 in two additional patients with sporadic Parkinson's disease. Although the EIF4G1 variants identified in the present study were not observed in control subjects, co-segregation analyses and population-based screening data suggest they are not pathogenic. In conclusion, we did not identify novel or previously reported pathogenic mutations (including the p.A502V and p.R1205H mutants) within EIF4G1 in the Japanese population, thus future studies are warranted to elucidate the role of this gene in Parkinson's disease.
EIF4G1基因的致病性突变最近被报道为常染色体显性帕金森症的一个病因。为评估日本人群中EIF4G1突变的频率,我们对95例明显呈常染色体显性遗传形式的帕金森病患者的整个基因编码区(31个外显子)进行了测序。我们在第10外显子内的一个聚谷氨酸重复序列中检测到三个新的点突变。这些变异通过来自日本人群的224例帕金森病病例和374例正常对照进行了筛查。我们在另外两名散发性帕金森病患者中检测到第10外显子中的聚谷氨酸缺失。虽然在本研究中鉴定出的EIF4G1变异在对照受试者中未观察到,但共分离分析和基于人群的筛查数据表明它们不具有致病性。总之,我们在日本人群中未在EIF4G1内鉴定出新的或先前报道的致病性突变(包括p.A502V和p.R1205H突变体),因此有必要进行进一步研究以阐明该基因在帕金森病中的作用。